期刊文献+

中医药干细胞研究及治疗与伦理学问题策略优化 被引量:2

Strategy optimization for ethical issues and stem cell research and treatment involving traditional Chinese medicine
原文传递
导出
摘要 为配合医院机构开展中医药干细胞研究,广东省中医院伦理委员会做了大量的理论技术准备工作,率先成立了全国首家中医药干细胞研究伦理委员会,并顺利地开展了中医药干细胞研究的伦理审查工作,为全国乃至全世界的中医药干细胞研究伦理审查起到示范性的作用。文章围绕上述核心问题从中医药干细胞研究及治疗的理论基础、特色及作用、过程管理与控制的既存问题、伦理学问题策略优化等部分展开论述,并就知情同意、风险控制、隐私保护等方面进行相关探讨,以期为当前中医药干细胞研究及治疗规范与伦理审查实践提供参考。 To cooperate with hospital establishment of TCM stem cell research and treatment, the ethics committee team in Guangdong Hospital of Traditional Chinese Medicine made a lot of preparatory work involving theoretical technology, and finally set up the first TCM Stem Cell Research Ethics Committee. All these efforts on ethical review for TCM stem cell research performed well, which played an exemplary role in this field at home and abroad. Based on the core problem and principles, this article attempted to discuss the issues such as theoretical basis, characteristics and functions of TCM stem cell research and treatment, existing problems of process control and management, strategy optimization for ethical issues, and further integrated informed consent, risk control, and privacy protection, etc. All these considerations arc hoped to provide references for TCM stem cell research and treatment and ethical review practice.
作者 刘军 曾令烽 关梓桐 母双 陆麒 曹倩 李晓彦 潘建科 刘强 梁伟雄 曾星 LIU Jull;ZENG Ling-feng;GUAN Zi-tong;MU Shuang;LU Qi;CAO Qian;LI Xiao-yan;PAN Jian-ke;LIU Qiang;LIANG Wei-xiong;ZENG Xing(No.2 Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Hospital of Traditional Chinese Medicine) Guangzhou 510120, China;ZSecond School of Clinic Medicine, Guangzhou University of Chinese Medicine, Guangzhou 510405, Chin;Bone and Joint Research Team of Degeneration and Injury, Guangdong Provincial Academy of Chinese Medical Sciences, Guangzhou 510120, China;World Federation of Chinese Medicine Societies, B eijing 100101, China;Medical Ethics Committee, Peking University People' s Hospital, B eij ing 100044, China;Ethics Committee, Renji Hospital, Medicine College of Shanghai Jiaotong University, Shanghai 200127, China)
出处 《中华中医药杂志》 CAS CSCD 北大核心 2018年第4期1226-1232,共7页 China Journal of Traditional Chinese Medicine and Pharmacy
基金 国家自然科学基金项目(No.81473698),国家中医药管理局中医药标准化项目(No.SATCM-2015-BZ115,No.SATCM-2015-BZ173),广东省财政厅项目(No.[2014]157号,No.[2018]8号),广东省中医院中医药科学技术研究专项项目(No.YK201382N19,No.YN2015MS15,No.YN2018QN),中国博士后科学基金资助项目和教育部高等学校博士点科研基金项目(No.20124425110004),国家工信部和国家卫计委“骨科手术机器人应用中心”建
关键词 中医药干预 干细胞 伦理审查 风险控制 伦理学问题 干细胞研究 干细胞治疗 Traditional Chinese medicine intervention Stem cell Ethical review Risk control Ethics issues Stem cell study Stem cell treatment
  • 相关文献

参考文献24

二级参考文献308

共引文献285

同被引文献55

引证文献2

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部